Chesley Taft & Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Chesley Taft & Associates's AGN Position: Q4 2017 in Review
Chesley Taft & Associates sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 4,026 shares — an estimated $825K sold.
Chesley Taft & Associates first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $7.18M in Q3 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Chesley Taft & Associates reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
- Chesley Taft & Associates sold 4,026 Allergan plc shares in Q4 2017, an estimated $825K.
- Chesley Taft & Associates first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
- Chesley Taft & Associates's Allergan plc position peaked at $7.18M in Q3 2016.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Chesley Taft & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.